Catalog No.
DHD10499
Description
Mirvetuximab soravtansine is an ADC consisting of an FRA-directed antibody and DM4 used for the study of ovarian cancer and other FRα-positive cancers.
Species reactivity
Human
Clonality
Monoclonal
Target
FRA
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Purification
Purified by Ion Exchange Chromatography.
Applications
Research Grade Biosimilar
Form
Liquid
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
ELAHERE, huFR107-SPDB-DM4
Clone ID
Mirvetuximab soravtansine
For research use only. Not for human or drug use.
